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ABSTRACT
Objective: Since conflicting results have been
published on the role of tobacco smoking on the risk
of endometriosis, we provide an up-to-date summary
quantification of this potential association.
Design: We performed a PubMed/MEDLINE search of
the relevant publications up to September 2014,
considering studies on humans published in English.
We searched the reference list of the identified papers
to find other relevant publications. Case–control as well
as cohort studies have been included reporting risk
estimates on the association between tobacco smoking
and endometriosis. 38 of the 1758 screened papers
met the inclusion criteria. The selected studies
included a total of 13 129 women diagnosed with
endometriosis.
Setting: Academic hospitals.
Main outcome measure: Risk of endometriosis in
tobacco smokers.
Results: We obtained the summary estimates of the
relative risk (RR) using the random effect model, and
assessed the heterogeneity among studies using the
χ2 test and quantified it using the I2 statistic. As
compared to never-smokers, the summary RR were
0.96 (95% CI 0.86 to 1.08) for ever smokers, 0.95
(95% CI 0.81 to 1.11) for former smokers, 0.92 (95%
CI 0.82 to 1.04) for current smokers, 0.87 (95% CI
0.70 to 1.07) for moderate smokers and 0.93 (95% CI
0.69 to 1.26) for heavy smokers.
Conclusions: The present meta-analysis provided no
evidence for an association between tobacco smoking
and the risk of endometriosis. The results were
consistent considering ever, former, current, moderate
and heavy smokers, and across type of endometriosis
and study design.
INTRODUCTION
Endometriosis is an oestrogen-dependent,
chronic inﬂammatory gynaecological condi-
tion characterised by the proliferation of
functional endometrial tissue that develops
outside the uterine cavity, which may cause
pain and infertility.1 However, despite its rela-
tively high prevalence, which spans from
20% in asymptomatic women2 to 30% in
women with infertility,3 and 45% in women
with pain symptoms,4 risk factors for this con-
dition remain largely unknown.
Among the risk factors investigated, some
studies have examined the role of tobacco
smoking. In a Portuguese study investigating
clinical and lifestyle factors in infertile
women, current smokers had a decreased
risk of endometriosis as compared to non-
smokers or former smokers.5 In a case–
control study from Turkey evaluating the
interaction between tobacco smoking and
glutathione-S-transferase gene polymorphism
as a risk factor for endometriosis, an inverse
association between smoking and endometri-
osis was observed.6 In a case–control study
carried out in the USA, infertile women with
endometriosis and fertile controls were com-
pared, and a decreased risk of endometriosis
was found, though limited to women who
had begun smoking at an early age and were
heavy smokers.7 Other studies did not ﬁnd
signiﬁcant association.3 8–14
The biological plausibility potentially
linking smoking and endometriosis resides in
its endocrine and inﬂammatory mechanisms.
Smoke compounds disrupt steroidogenesis,
leading to impairment of E2 synthesis15 16
and progesterone synthesis deﬁciency.17–19
Strengths and limitations of this study
▪ Meta-analysis including 38 papers without any
relevant asymmetry in the funnel plot.
▪ The Egger’s test was not statistically significant.
▪ In some studies, choice of cases as asymptom-
atic without distinguishing factors related to
endometriosis to those associated with pelvic
pain or infertility.
▪ In some studies, choice of controls in whom
disease was not laparoscopically ruled out.
▪ Tobacco smoking based on patients’ self-
reported information.
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Moreover, smoking has a strong effect on inﬂammatory
mediators in the pulmonary as well as extra-pulmonary
environments and can further trigger inﬂammation asso-
ciated with the disease, resulting in pro-inﬂammatory
gene overexpression.20
A clear deﬁnition of the relation between smoking and
endometriosis risk is required in order to better under-
stand the role of oestrogens, in consideration of the
potential antioestrogenic effect of smoking. Otherwise,
in clinical terms, a direct association as reported in some
studies6 7 may suggest preventive measures.
Thus, in order to investigate the possible relation
between tobacco smoking and endometriosis, and to
provide an overall quantitative estimate of any such rela-
tion, we combined all published data on the issue in a
meta-analysis.
MATERIALS AND METHODS
Search strategy
We performed a PubMed/MEDLINE search of papers
published between 1966 and September 2014, using the
terms “tobacco” or “smoking” or “cigarette” in combin-
ation with “risk factor” or “epidemiology”, and “endo-
metriosis”, following the MOOSE (Meta-analysis of
Observational Studies in Epidemiology) guidelines21;
details on the search terms are provided in online sup-
plementary appendix. We selected only studies on
humans, published as full-length papers in English. No
effort was made to identify papers published in other
languages or unpublished studies. Moreover, we
reviewed the reference lists of the retrieved papers to
identify any other relevant publications. Studies were
included in the meta-analysis if: (1) they were based on
case–control or cohort studies, reporting original data;
(2) they reported information on the association
between tobacco smoking and endometriosis, including
estimates of the relative risk (RR) (approximated by the
odds ratio (OR), in case-control studies), with the corre-
sponding 95% CIs, or frequency distribution to calculate
them; (3) diagnosis of endometriosis was histologically
conﬁrmed and/or clinically based. When we found
more than one publication based on the same study
population and data, we included only the one with
most detailed information, or published most recently.
We used the Newcastle-Ottawa Scale22 to assess the
quality of individual studies and performed a sensitivity
analysis according to the quality of each study.
Data extraction for the meta-analysis
Two authors (FB and SC) reviewed the manuscripts and
independently selected the eligible manuscripts; dis-
agreements were resolved by discussion. From each pub-
lication we extracted the following information: country
of origin; study design; number and characteristics of
subjects (cases, controls or cohort size); age, if available;
categories of tobacco smoking, if available; measures of
association (RR or OR) of endometriosis and
corresponding 95% CI for every category of tobacco
smoking, or frequency distribution to calculate them;
and confounding variables allowed for in the statistical
analysis, if any. When more than one regression model
was provided, estimates adjusted for the largest number
of confounding variables were considered.
Statistical analysis
For some studies, we pooled estimates of different categor-
ies of cases or controls using the method by Hamling
et al,23 which allows combining of the estimates originally
shown in the paper, changing the reference category and
taking into account their correlation. We obtained the
summary estimates of the RR using the random effect
model (ie, as weighed averages on the sum of the inverse
of the variance of the log RR and the moment estimator of
the variance between studies).24 We assessed the hetero-
geneity among studies using the χ2 test25 and quantiﬁed it
using the I2 statistic, which represents the percentage of
the total variation across studies that is attributable to het-
erogeneity rather than chance.26 Results were deﬁned as
heterogeneous for p values less than 0.10.
We computed summary estimates for ever tobacco
smokers, former smokers, current smokers, moderate
current smokers and heavy current smokers, as com-
pared to never-smokers. Different cut-points for moder-
ate and heavy smoking were chosen, depending on
those shown in the papers. We also carried out a cumu-
lative meta-analysis to determine whether the association
between tobacco smoking and endometriosis changed
over time. In the cumulative meta-analysis, studies are
added one at a time, ordered by year of publication, and
the results are pooled as each new study is added. In the
graph, the vertical line corresponding to each year
represents the RR and corresponding CI of the results
of the meta-analysis of the studies published up to that
year, rather than the results of a single study.27
Furthermore, we performed subgroup analyses accord-
ing to the type of controls (fertile, infertile, both/not
speciﬁed). Publication bias was evaluated using a funnel
plot28 and was quantiﬁed by the Egger’s test.29
RESULTS
Figure 1 shows the ﬂow chart of the selection of publica-
tions. The literature search yielded 1758 reports, of
which 1620 were excluded after evaluation of abstract
and full text, because they did not report any informa-
tion on the relationship between tobacco smoking and
risk of endometriosis, and 80 because they did not
satisfy the inclusion criteria. Moreover, four studies were
not comparable with the others, since reported estimates
for lifetime smoking30 included former or light smokers
in the reference category,11 included women with stage I
endometriosis in the comparison group,31 or reported
serum cotinine as measure of exposure to tobacco
smoking (including passive smoking),32 and thus we
excluded those studies from the meta-analysis.
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Furthermore, we excluded 16 studies based on the same
data of other included publications.33–48 Thus, in the
present meta-analysis we combined data from 38 studies,
including a total of 13 129 women with endometriosis (see
online supplementary ﬁle table S1).3 5–10 12–14 49–76
Online supplementary ﬁle table S1 shows the main
characteristics of the studies included in the present
meta-analysis. Most publications were based on case–
control studies, while nine were cohort studies in which,
however, the role of smoking was evaluated at the same
time of the disease diagnosis,13 50 52 54 58 70 74 except in
two cases, in which smoking status was assessed at
baseline.5 49 Of these, 16 studies were from
Europe,3 5 9 10 49 52 54–57 60 62 66 68 69 71 13 from the
USA,7 12–14 50 53 58 61 64 65 67 70 72 2 from Canada,8 63
5 from Asia6 51 59 74 75 and 2 from Australia.73 76
Twenty-four studies reported information on ever
smokers,5 7–10 13 14 49 50 52 54 56 57 60 61 64 67 68 71–76 16 on
former smokers5 7–10 13 52 54 56 57 61 64 68 71–73 and 30 on
current smokers.3 5–10 12 13 51–59 61–66 68–73 Among these,
eight reported more categories of current smokers, thus
we could calculate separate estimates for moderate and
heavy current smokers. We used different cut-points for
various study populations, depending on those presented
in the papers: thus the cut-point between moderate and
heavy smokers was deﬁned as 20 cigarettes per day in ﬁve
studies,5 8 53 71 72 15 cigarettes per day in two studies13 58
and 10 cigarettes per day in one study.10
For some studies reporting separate estimates for dif-
ferent types of patients and/or controls, we computed a
pooled estimate. In particular, Coccia et al52 reported
separate estimates for monolateral and bilateral endo-
metriosis, Heilier et al57 for endometriosis and deep
endometriotic nodules, Parazzini et al68 for deep endo-
metriosis, and pelvic and ovarian endometriosis,
Signorello et al14 for fertile and infertile controls, and
Tsuchiya et al75 for stage I/II and stage III/IV endometri-
osis. Moreover, Calhaz-Jorge et al5 reported separate esti-
mates for grade I/II and grade III/IV endometriosis, as
well as for any type of endometriosis, and the Gruppo
Italiano per lo Studio dell’endometriosi,10 including two
separate groups of cases and controls undergoing lapar-
oscopy for pelvic pain or infertility, showed separate as
well as pooled estimate; in both cases we included the
combined estimates in the meta-analysis; further, Pollack
et al70 included an operative cohort comprising women
scheduled for laparoscopy/laparotomy and an age-
matched population cohort of women who underwent
pelvic MR for the detection of endometriosis, and we
summed up the two groups.
Considering ever smokers or, separately, former
smokers, current smokers, moderate smokers and heavy
smokers, no statistically signiﬁcant association emerged
(ﬁgures 2–4).
Figure 5 shows the funnel plot for ever smokers versus
non-smokers. There was no evidence of publication bias
(p=0.054).
When we restricted the analyses to nine studies report-
ing risk estimates adjusted for confounding variables,
risk estimates were 1.01 (95% CI 0.86 to 1.19) for ever
smokers, 0.94 (95% CI 0.85 to 1.03) for former smokers,
0.87 (95% CI 0.64 to 1.17) for current smokers, 0.85
(95% CI 0.60 to 1.20) for moderate current smokers
and 0.90 (95% CI 0.57 to 1.43) for heavy current
smokers versus never-smokers.
In subgroup analyses according to type of controls, esti-
mates for ever smokers versus non-smokers were 1.06
(95% CI 0.89 to 1.27) for 7 studies including fertile
women, 0.92 (95% CI 0.75 to 1.12) for 7 studies including
infertile women and 0.95 (95% CI 0.81 to 1.12) for 14
studies including both or not speciﬁed types of controls.
Moreover, when we restricted the analyses to studies with
cases and controls laparoscopically or surgically con-
ﬁrmed, the risk estimates were 0.97 (95% CI 0.87 to 1.07)
for ever smokers, 0.94 (95% CI 0.85 to 1.03) for former
smokers, 0.90 (95% CI 0.77 to 1.04) for current smokers,
0.86 (95% CI 0.66 to 1.12) for moderate smokers and
0.97 (95% CI 0.70 to 1.35) for heavy smokers.
Quality score ranged between 2 and 7 (median 4.5).
When we restricted the meta-analysis to 19 high-quality
studies (with quality score ≥5) the pooled estimates did
not materially change (data not shown). Figure 6 shows
the cumulative meta-analysis of endometriosis risk for
ever smokers versus non-smokers over time, from 1986
to 2014: small variations in the RR estimates emerged
over time.
Figure 1 Flow chart of the selection of studies on tobacco
smoking and risk of endometriosis included in the
meta-analysis.
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DISCUSSION
The present meta-analysis does not support an associ-
ation between smoking and endometriosis risk. No asso-
ciation emerged considering subgroups of ever, former,
current, moderate and heavy smokers, nor in sensitivity
and subgroup analyses.
However, this work may be affected by limitations and
biases intrinsic to the original observational studies
included in the meta-analysis, as well as to the limits that
we chose to apply to the bibliographic search, including
the restriction to searching PubMed only and the exclu-
sion of languages other than English. Regarding the
characteristics of the observational studies, a major
concern is the ascertainment of the presence or absence
of endometriosis. Some studies compared symptomatic
cases with asymptomatic controls, and thus could not
distinguish factors related to endometriosis with those
associated with pelvic pain or infertility. Moreover, gener-
ally asymptomatic controls did not undergo laparoscopy
or other surgical procedures, and therefore the presence
of asymptomatic endometriosis in these women cannot
be ruled out. Another concern is the fact that in some
studies diagnosis of endometriosis was self-reported.
Thus, a misclassiﬁcation of cases and controls could not
be deﬁnitively excluded. However, when we restricted
the analyses to women in whom laparoscopy or a surgi-
cal procedure had conﬁrmed the presence or absence
of endometriotic lesions, we still did not ﬁnd any signiﬁ-
cant association between smoking and endometriosis.
Further, tobacco smoking is based on patients’ self-
reported information, thus some misclassiﬁcation may
have occurred. However, information on tobacco
smoking in observational studies has been shown to be
satisfactorily reproducible and valid.77–79 For most
studies included in the present meta-analysis, only raw
estimates were available, since tobacco smoking was not
the main topic of the paper and it was only reported as
a confounding variable. However, estimates from these
studies were similar to those from studies speciﬁcally
investigating the role of smoking, thus allowing us to
rule out major publication bias on this issue. Moreover,
we did not ﬁnd any relevant asymmetry in the funnel
plot, and the Egger’s test was not statistically signiﬁcant.
Thus, publication bias is unlikely to have appreciably
modiﬁed the relation between tobacco smoking and
endometriosis. Although previous studies have reported
Figure 2 Study-specific and summary relative risks (RR) of endometriosis for ever smokers versus never-smokers.
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Figure 3 Study-specific and summary relative risks (RR) of endometriosis for current (A) and former smokers (B) versus
never-smokers.
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an association between endometriosis and menstrual
and reproductive factors, such as early menarche,7 12
longer duration of bleeding,7 intra-uterine device use,80
or a lifelong regular menstrual pattern of shorter cycles
and heavy ﬂows,7 12 72 81 nulliparity or low
parity,14 30 38 82 only some studies included in the
present meta-analysis have accounted for the role of
these factors in the estimate of the relation between
tobacco smoking and endometriosis. However, analyses
based on adjusted estimates only were comparable to
those based on raw estimates.
Since endometriosis is an oestrogen-dependent condi-
tion, the inverse association between smoking and endo-
metriosis found in some studies has generally been
attributed to the anti-oestrogenic effect of tobacco.83
Some authors have suggested that oestradiol might
modulate the mediators of immune system molecules or
those involved in tissue cell adhesion and invasion.84 85
Moreover, a favourable effect of smoking has been
observed in other benign and malignant oestrogen-
related diseases, such as endometrial cancer86 and
ﬁbroids.87 The antioestrogenic effect of smoking on
these conditions could support a protective effect of
smoking on endometriosis. Indeed, earlier studies
tended to support some inverse association, which,
however, declined over time, and accumulating evidence
suggests the presence of some false-positive ﬁndings in
earlier studies.88 Furthermore, tobacco smoking has been
associated with female infertility,89 and thus the interpret-
ation of the relation between smoking and endometriosis
may be inﬂuenced by the role of infertility.
Despite the high prevalence of this condition, the epi-
demiology of endometriosis still needs to be elucidated
for several reasons. Endometriosis is a complex condition
in which a genetic contribution and environmental
factors seem to be involved.90 Further, it is a disease char-
acterised by an yet poorly deﬁned phenotype. The
disease stage depends on the type (cysts, implants,
nodules), location (ovary, peritoneum, bladder, ureter,
etc), and appearance and depth of invasion of the
lesions, which can vary greatly among patients. The clin-
ical presentation can be so variable and the lesions of
such diverse morphology that none of the pathogenetic
models proposed (retrograde menstruation, coelomic
metaplasia, embryological origin) can fully explain the
various aspects of endometriosis, and none has been
recognised as an ultimately valid explanatory model for
all the different forms and manifestations of the
disease.90 Moreover, an invasive procedure is needed to
diagnose it.90 91 Furthermore, published studies differ in
the case and control selection and population deﬁnition,
depending on the choices to consider fertile or infertile
cases, and healthy controls or patients with conditions
other than endometriosis. Despite these possible sources
of variation, the consistency of results observed weighs
against any relevant role of tobacco on endometriosis.
Figure 4 Study-specific and summary relative risks (RR) of endometriosis for moderate (A) and heavy (B) current smokers
versus never-smokers.
Figure 5 Funnel plot of studies on tobacco smoking and risk
of endometriosis (RR, relative risk for ever smokers versus
never-smokers).
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In conclusion, the present meta-analysis failed to iden-
tify an association between tobacco smoking and endo-
metriosis. However, given the possible limitations of the
present study, further studies are needed to evaluate, in
depth, the relationship and potential effect of smoking
on different type of endometriosis.
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